HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Wade, M. M. Articles by Zhang, Y. Search for Related Content PubMed PubMed Citation Articles by Wade, M. M. Articles by Zhang, Y. Agricola Articles by Wade, M. M. Articles by Zhang, Y.

Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis

Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA

Correspondence: Ying Zhang yzhang{at}jhsph.edu

Received February 18, 2004
Accepted April 23, 2004

Pyrazinamide (PZA) is an unconventional front line tuberculosis drug characterized by high in vivo sterilizing activity, but poor in vitro activity. This disparity in PZA activity may reflect differences between the in vivo tissue environment and in vitro culture conditions. This study examined the effect of anaerobic conditions, which exist in granulomatous lesions in vivo, on PZA activity in vitro. Low oxygen enhanced the activity of PZA against Mycobacterium tuberculosis, with anaerobic conditions resulting in greater enhancement than microaerobic conditions. ATPase and respiratory chain enzyme inhibitors enhanced PZA activity under normal atmospheric conditions, but not under anaerobic conditions. Furthermore, the inhibitors did not enhance isoniazid or rifampicin activity. Nitrate as an alternative electron acceptor antagonized PZA activity under anaerobic conditions. These findings provide further support for a proposed mechanism of action of PZA in which the active form of PZA (pyrazinoic acid) depletes the membrane energy reserve. They also provide another explanation for the higher sterilizing activity of PZA within in vivo lesions with low oxygen than under in vitro drug susceptibility testing conditions with ambient oxygen.

This article has been cited by other articles:

				P. Gu, L. Constantino, and Y. Zhang Enhancement of the antituberculosis activity of weak acids by inhibitors of energy metabolism but not by anaerobiosis suggests that weak acids act differently from the front-line tuberculosis drug pyrazinamide J. Med. Microbiol., September 1, 2008; 57(9): 1129 - 1134. [Abstract] [Full Text] [PDF]

				C. D. Sohaskey Nitrate Enhances the Survival of Mycobacterium tuberculosis during Inhibition of Respiration J. Bacteriol., April 15, 2008; 190(8): 2981 - 2986. [Abstract] [Full Text] [PDF]

				S. H. Cho, S. Warit, B. Wan, C. H. Hwang, G. F. Pauli, and S. G. Franzblau Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosis Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1380 - 1385. [Abstract] [Full Text] [PDF]

				M. M. Wade and Y. Zhang Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro J. Antimicrob. Chemother., November 1, 2006; 58(5): 936 - 941. [Abstract] [Full Text] [PDF]

				D. F. Warner and V. Mizrahi Tuberculosis Chemotherapy: the Influence of Bacillary Stress and Damage Response Pathways on Drug Efficacy Clin. Microbiol. Rev., July 1, 2006; 19(3): 558 - 570. [Abstract] [Full Text] [PDF]

				C. D. Sohaskey Regulation of nitrate reductase activity in Mycobacterium tuberculosis by oxygen and nitric oxide Microbiology, November 1, 2005; 151(11): 3803 - 3810. [Abstract] [Full Text] [PDF]